Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Board of Pharmacy; regulation of psilocybin. Directs the Board of Pharmacy to reschedule psilocybin consistent with federal scheduling upon approval by the U.S. Food and Drug Administration of a formulation of psilocybin designed to be administered by a health care professional in a health care setting. This bill is identical to HB 1347.
Introduced
Jan 13, 2026
Last Action
Mar 10, 2026
Session
VA 2026
Sponsors
1 primary · 1 co
Governor's Action Deadline 11:59 p.m., April 13, 2026
Enrolled Bill communicated to Governor on March 10, 2026
Signed by Speaker
Fiscal Impact Statement from Department of Planning and Budget (SB379)
Bill text as passed Senate and House (SB379ER)
Signed by President
Enrolled
Passed House (98-Y 0-N 0-A)
Read third time
Read second time
Reported from Health and Human Services (21-Y 0-N)
Read first time
Referred to Committee on Health and Human Services
Placed on Calendar
Fiscal Impact Statement from Department of Planning and Budget (SB379)
Read third time and passed Senate (40-Y 0-N 0-A)
Engrossed by Senate - committee substitute Block Vote (Voice Vote)
Education and Health Substitute agreed to
Read second time
Rules suspended
Committee substitute printed 26106612D-S1
Passed by for the day
Passed by for the day (Voice Vote)
Constitutional reading dispensed (on 1st reading) (39-Y 0-N 0-A)
Reported from Education and Health with substitute (14-Y 0-N)
Assigned Education sub: Health Professions
Senate subcommittee offered
Fiscal Impact Statement from Department of Planning and Budget (SB379)
Referred to Committee on Education and Health
Prefiled and ordered printed; Offered 01-14-2026 26104820D
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Governor's Action Deadline 11:59 p.m., April 13, 2026
Jennifer B. Boysko
Scott A. Surovell